rs181646656

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_004380.3(CREBBP):​c.5988C>T​(p.Ala1996Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.011 in 1,584,672 control chromosomes in the GnomAD database, including 257 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0078 ( 22 hom., cov: 32)
Exomes 𝑓: 0.011 ( 235 hom. )

Consequence

CREBBP
NM_004380.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.14

Publications

4 publications found
Variant links:
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
  • Rubinstein-Taybi syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • Rubinstein-Taybi syndrome due to CREBBP mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • Menke-Hennekam syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 16-3729059-G-A is Benign according to our data. Variant chr16-3729059-G-A is described in ClinVar as Benign. ClinVar VariationId is 95058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00784 (1194/152214) while in subpopulation SAS AF = 0.0537 (259/4824). AF 95% confidence interval is 0.0483. There are 22 homozygotes in GnomAd4. There are 627 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1194 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
NM_004380.3
MANE Select
c.5988C>Tp.Ala1996Ala
synonymous
Exon 31 of 31NP_004371.2Q92793-1
CREBBP
NM_001079846.1
c.5874C>Tp.Ala1958Ala
synonymous
Exon 30 of 30NP_001073315.1Q92793-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CREBBP
ENST00000262367.10
TSL:1 MANE Select
c.5988C>Tp.Ala1996Ala
synonymous
Exon 31 of 31ENSP00000262367.5Q92793-1
CREBBP
ENST00000382070.7
TSL:1
c.5874C>Tp.Ala1958Ala
synonymous
Exon 30 of 30ENSP00000371502.3Q92793-2

Frequencies

GnomAD3 genomes
AF:
0.00785
AC:
1194
AN:
152096
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00162
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00825
Gnomad ASJ
AF:
0.0475
Gnomad EAS
AF:
0.0103
Gnomad SAS
AF:
0.0534
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00709
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0150
AC:
3017
AN:
200776
AF XY:
0.0175
show subpopulations
Gnomad AFR exome
AF:
0.00145
Gnomad AMR exome
AF:
0.00497
Gnomad ASJ exome
AF:
0.0464
Gnomad EAS exome
AF:
0.0145
Gnomad FIN exome
AF:
0.00150
Gnomad NFE exome
AF:
0.00828
Gnomad OTH exome
AF:
0.0140
GnomAD4 exome
AF:
0.0113
AC:
16217
AN:
1432458
Hom.:
235
Cov.:
33
AF XY:
0.0127
AC XY:
9011
AN XY:
711678
show subpopulations
African (AFR)
AF:
0.00188
AC:
62
AN:
33016
American (AMR)
AF:
0.00535
AC:
225
AN:
42058
Ashkenazi Jewish (ASJ)
AF:
0.0463
AC:
1192
AN:
25740
East Asian (EAS)
AF:
0.0203
AC:
780
AN:
38478
South Asian (SAS)
AF:
0.0497
AC:
4164
AN:
83800
European-Finnish (FIN)
AF:
0.00194
AC:
80
AN:
41144
Middle Eastern (MID)
AF:
0.0308
AC:
177
AN:
5742
European-Non Finnish (NFE)
AF:
0.00788
AC:
8688
AN:
1103036
Other (OTH)
AF:
0.0143
AC:
849
AN:
59444
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1128
2257
3385
4514
5642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
388
776
1164
1552
1940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00784
AC:
1194
AN:
152214
Hom.:
22
Cov.:
32
AF XY:
0.00843
AC XY:
627
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41548
American (AMR)
AF:
0.00824
AC:
126
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0475
AC:
165
AN:
3472
East Asian (EAS)
AF:
0.0101
AC:
52
AN:
5156
South Asian (SAS)
AF:
0.0537
AC:
259
AN:
4824
European-Finnish (FIN)
AF:
0.00122
AC:
13
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00709
AC:
482
AN:
67988
Other (OTH)
AF:
0.0118
AC:
25
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
59
118
177
236
295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0119
Hom.:
5
Bravo
AF:
0.00709
Asia WGS
AF:
0.0300
AC:
104
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Rubinstein-Taybi syndrome (1)
-
-
1
Rubinstein-Taybi syndrome due to CREBBP mutations;C5193034:Menke-Hennekam syndrome 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
2.9
DANN
Benign
0.72
PhyloP100
1.1
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181646656; hg19: chr16-3779060; COSMIC: COSV107273010; COSMIC: COSV107273010; API